Filtered By:
Source: Drug Safety
Condition: Thrombosis
Management: WHO
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase ®
Conclusion
This study suggests the presence of a signal for an increased risk of thrombosis with eltrombopag compared with romiplostim. These results must be confirmed and quantified by large aetiological pharmacoepidemiological studies.
Source: Drug Safety - September 4, 2015 Category: Drugs & Pharmacology Source Type: research
